Holen Sie sich die Stockscreener-App
3.13
4.33%
0.13
Handel nachbörslich:
3.16
0.03
+0.96%
Schlusskurs vom Vortag:
$3.00
Offen:
$2.98
24-Stunden-Volumen:
171.14K
Relative Volume:
0.25
Marktkapitalisierung:
$5.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.42M
KGV:
-1.7011
EPS:
-1.84
Netto-Cashflow:
$-13.41M
1W Leistung:
+14.23%
1M Leistung:
+20.38%
6M Leistung:
-75.68%
1J Leistung:
+222.68%
1-Tages-Spanne:
$2.9301
$3.1999
1-Wochen-Bereich:
$2.41
$3.1999
52-Wochen-Spanne:
$0.2701
$13.40
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Vergleichen Sie INDP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
3.13 | 5.25M | 0 | -15.42M | -13.41M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Will Indaptus Therapeutics Inc. stock recover faster than marketFit and Size Notes & lightweight options for faster days - ulpravda.ru
Indaptus Therapeutics appoints David Natan to board and audit committee - Investing.com
Indaptus Therapeutics Appoints David Natan to Board - TipRanks
Will Indaptus Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Technicals & Entry Point Confirmation Alerts - ulpravda.ru
How analysts rate Indaptus Therapeutics Inc. stock todayEarnings Risk Report & Weekly Hot Stock Watchlists - ulpravda.ru
Why did INDP stock gain 12% today? - MSN
Indaptus Therapeutics announces upcoming board leadership transition - MSN
Three Indaptus Therapeutics board members signal planned resignations - Investing.com
Three Indaptus Therapeutics board members signal planned resignations By Investing.com - Investing.com India
Indaptus Therapeutics Announces Board Resignations - TradingView — Track All Markets
Indaptus Therapeutics, Inc. (NASDAQ:INDP) Short Interest Up 25.9% in December - Defense World
Indaptus Therapeutics looks to raise $2.25M in private placement - MSN
Biotech Stocks To Keep An Eye OnDecember 24th - MarketBeat
Indaptus Therapeutics Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - marketscreener.com
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - The Globe and Mail
Indaptus Therapeutics secures $6 million investment, names new chairman By Investing.com - Investing.com Nigeria
Why Did INDP Stock Gain 12% Today? - Stocktwits
Indaptus Therapeutics stock falls after $6 million securities deal By Investing.com - Investing.com Nigeria
Indaptus Therapeutics stock falls after $6 million securities deal - Investing.com
Penny Stocks Worth Watching – December 25th - Defense World
What Does the Market Think About Indaptus Therapeutics Inc? - Benzinga
Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Indaptus Therapeutics Inc.: Are They Ready for Takeoff? - StocksToTrade
Indaptus Therapeutics, Inc.Common Stock (Nasdaq:INDP) Stock Quote - FinancialContent
Is It Too Late to Buy INDP Stock? - timothysykes.com
Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question - ts2.tech
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Benzinga
Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Sahm
Indaptus Therapeutics : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Trending Stocks Today | Indaptus Therapeutics Soars 52.9% Post-Market - 富途牛牛
Indaptus Therapeutics Inc appoints David Lazar as co-chief executive officer - marketscreener.com
Indaptus Therapeutics Signs Securities Purchase Agreement With David Lazar - TradingView — Track All Markets
INDP Files 8-K with SEC - Stock Titan
Indaptus Therapeutics, Inc. announced that it has received $6 million in funding - marketscreener.com
Indaptus Therapeutics, Inc. announced that it expects to receive $6 million in funding - marketscreener.com
Can Indaptus Therapeutics Inc. stock hit record highs again2025 Top Gainers & Precise Entry and Exit Recommendations - Улправда
How buybacks impact Indaptus Therapeutics Inc. stock valueTrade Analysis Summary & AI Forecast for Swing Trade Picks - Улправда
Breakout Move: Is Indaptus Therapeutics Inc stock attractive for hedge fundsJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - moha.gov.vn
Will Indaptus Therapeutics Inc. stock outperform value stocksShort Setup & Weekly High Potential Stock Alerts - DonanımHaber
Is Indaptus Therapeutics Inc. stock a good choice for value investors2025 Valuation Update & Long Hold Capital Preservation Plans - ulpravda.ru
Published on: 2025-12-19 01:13:33 - moha.gov.vn
Indaptus Therapeutics Earnings Notes - Trefis
Indaptus Therapeutics (NASDAQ:INDP) Downgraded by Wall Street Zen to “Sell” - Defense World
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):